Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer

Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer

US Patent 7964575 · Granted Jun 21, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of preparing a poloxamer for use in cell culture medium2024
Methods of preparing a poloxamer for use in cell culture medium2021
Methods for viral inactivation and other adventitious agents2019
Methods for viral inactivation and other adventitious agents2016
Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic an2015
Beta carboline derivatives useful in the treatment of proliferative disorders2015
Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory2014
2″ oxo-voruscharin and derivatives thereof2011
Azonafide derivatives, methods for their production and pharmaceutical compositi2010
2″ oxo-voruscharin and derivatives thereof2008
Phenanthroline-7-one derivatives and their therapeutic uses2004
Pharmaceutical compositions comprising 4-quinolones for treating cancers2003